Biomarin Pharmaceutical Inc (BMRN)
81.03
-0.69
(-0.84%)
USD |
NASDAQ |
May 10, 16:00
81.00
-0.03
(-0.04%)
After-Hours: 20:00
Biomarin Pharmaceutical Max Drawdown (5Y): 56.90% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 56.90% |
March 31, 2024 | 56.90% |
February 29, 2024 | 56.90% |
January 31, 2024 | 56.90% |
December 31, 2023 | 56.90% |
November 30, 2023 | 56.90% |
October 31, 2023 | 56.90% |
September 30, 2023 | 56.90% |
August 31, 2023 | 56.90% |
July 31, 2023 | 56.90% |
June 30, 2023 | 56.90% |
May 31, 2023 | 56.90% |
April 30, 2023 | 56.90% |
March 31, 2023 | 56.90% |
February 28, 2023 | 56.90% |
January 31, 2023 | 56.90% |
December 31, 2022 | 56.90% |
November 30, 2022 | 56.90% |
October 31, 2022 | 56.90% |
September 30, 2022 | 56.90% |
August 31, 2022 | 56.90% |
July 31, 2022 | 56.90% |
June 30, 2022 | 56.90% |
May 31, 2022 | 56.90% |
April 30, 2022 | 56.90% |
Date | Value |
---|---|
March 31, 2022 | 56.90% |
February 28, 2022 | 56.90% |
January 31, 2022 | 56.90% |
December 31, 2021 | 56.90% |
November 30, 2021 | 56.90% |
October 31, 2021 | 56.90% |
September 30, 2021 | 56.90% |
August 31, 2021 | 56.90% |
July 31, 2021 | 56.90% |
June 30, 2021 | 56.90% |
May 31, 2021 | 56.90% |
April 30, 2021 | 56.90% |
March 31, 2021 | 56.90% |
February 28, 2021 | 56.90% |
January 31, 2021 | 56.90% |
December 31, 2020 | 56.90% |
November 30, 2020 | 56.90% |
October 31, 2020 | 56.90% |
September 30, 2020 | 56.90% |
August 31, 2020 | 56.90% |
July 31, 2020 | 56.90% |
June 30, 2020 | 56.90% |
May 31, 2020 | 56.90% |
April 30, 2020 | 56.90% |
March 31, 2020 | 56.90% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
56.59%
Minimum
May 2019
56.90%
Maximum
Oct 2019
56.88%
Average
56.90%
Median
Oct 2019
Max Drawdown (5Y) Benchmarks
Pfizer Inc | 54.78% |
Eli Lilly and Co | 22.48% |
Ligand Pharmaceuticals Inc | 77.41% |
Blueprint Medicines Corp | 69.50% |
Moderna Inc | 85.65% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -6.986 |
Beta (5Y) | 0.3407 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 34.59% |
Historical Sharpe Ratio (5Y) | -0.0922 |
Historical Sortino (5Y) | -0.1275 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 12.94% |